SHMT2 and colorectal cancer: SHMT2 may be an oncogene (Lee et al., 2014), the succinylation of SHMT2 at K280 sites inhibits colorectal cancer cell growth (Yang et al., 2018); however, so far, no relevant literature on the association of SHMT2 with BLCA has been reported.